New from #ASH24 - Beam Therapeutics, Prime Medicine & Vertex Pharmaceuticals lead the next chapter of companies pursuing development of nontoxic conditioning regimens, which would broaden access to genetic treatments statnews.com/2024/12/09/sic… via @statnews.bsky.social @adamfeuerstein.bsky.social

So thankful for 1AB and the opportunity to work every day alongside this amazing group of people on the best client roster in all of biotech.

Monopolies even on breakthrough drugs rarely last, as a new treatment from BridgeBioPharma $BBIO for heart disease shows. wsj.com/opinion/a-shor… via @wsj.com